Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) High Affinity Nerve Growth Factor Receptor Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 ASP-7962
      • 1.3.3 AZD-7451
      • 1.3.4 BNN-27
      • 1.3.5 Cenegermin
      • 1.3.6 CRB-0089
      • 1.3.7 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global High Affinity Nerve Growth Factor Receptor Market Share by Application (2019-2025)
      • 1.4.2 Bile Duct Cancer
      • 1.4.3 Papillary Thyroid Cancer
      • 1.4.4 Low Back Pain
      • 1.4.5 Lung Cancer
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global High Affinity Nerve Growth Factor Receptor Market Size
      • 2.1.1 Global High Affinity Nerve Growth Factor Receptor Revenue 2014-2025
      • 2.1.2 Global High Affinity Nerve Growth Factor Receptor Sales 2014-2025
    • 2.2 High Affinity Nerve Growth Factor Receptor Growth Rate by Regions
      • 2.2.1 Global High Affinity Nerve Growth Factor Receptor Sales by Regions 2014-2019
      • 2.2.2 Global High Affinity Nerve Growth Factor Receptor Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 High Affinity Nerve Growth Factor Receptor Sales by Manufacturers
      • 3.1.1 High Affinity Nerve Growth Factor Receptor Sales by Manufacturers 2014-2019
      • 3.1.2 High Affinity Nerve Growth Factor Receptor Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 High Affinity Nerve Growth Factor Receptor Revenue by Manufacturers (2014-2019)
      • 3.2.2 High Affinity Nerve Growth Factor Receptor Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio (CR5 and HHI)
    • 3.3 High Affinity Nerve Growth Factor Receptor Price by Manufacturers
    • 3.4 Key Manufacturers High Affinity Nerve Growth Factor Receptor Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into High Affinity Nerve Growth Factor Receptor Market
    • 3.6 Key Manufacturers High Affinity Nerve Growth Factor Receptor Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 ASP-7962 Sales and Revenue (2014-2019)
      • 4.1.2 AZD-7451 Sales and Revenue (2014-2019)
      • 4.1.3 BNN-27 Sales and Revenue (2014-2019)
      • 4.1.4 Cenegermin Sales and Revenue (2014-2019)
      • 4.1.5 CRB-0089 Sales and Revenue (2014-2019)
      • 4.1.6 Others Sales and Revenue (2014-2019)
    • 4.2 Global High Affinity Nerve Growth Factor Receptor Sales Market Share by Type
    • 4.3 Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type
    • 4.4 High Affinity Nerve Growth Factor Receptor Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global High Affinity Nerve Growth Factor Receptor Sales by Application

    6 United States

    • 6.1 United States High Affinity Nerve Growth Factor Receptor Breakdown Data by Company
    • 6.2 United States High Affinity Nerve Growth Factor Receptor Breakdown Data by Type
    • 6.3 United States High Affinity Nerve Growth Factor Receptor Breakdown Data by Application

    7 European Union

    • 7.1 European Union High Affinity Nerve Growth Factor Receptor Breakdown Data by Company
    • 7.2 European Union High Affinity Nerve Growth Factor Receptor Breakdown Data by Type
    • 7.3 European Union High Affinity Nerve Growth Factor Receptor Breakdown Data by Application

    8 China

    • 8.1 China High Affinity Nerve Growth Factor Receptor Breakdown Data by Company
    • 8.2 China High Affinity Nerve Growth Factor Receptor Breakdown Data by Type
    • 8.3 China High Affinity Nerve Growth Factor Receptor Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World High Affinity Nerve Growth Factor Receptor Breakdown Data by Company
    • 9.2 Rest of World High Affinity Nerve Growth Factor Receptor Breakdown Data by Type
    • 9.3 Rest of World High Affinity Nerve Growth Factor Receptor Breakdown Data by Application
    • 9.4 Rest of World High Affinity Nerve Growth Factor Receptor Breakdown Data by Countries
      • 9.4.1 Rest of World High Affinity Nerve Growth Factor Receptor Sales by Countries
      • 9.4.2 Rest of World High Affinity Nerve Growth Factor Receptor Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Array BioPharma Inc
      • 10.1.1 Array BioPharma Inc Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of High Affinity Nerve Growth Factor Receptor
      • 10.1.4 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 10.1.5 Array BioPharma Inc Recent Development
    • 10.2 Astellas Pharma Inc
      • 10.2.1 Astellas Pharma Inc Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of High Affinity Nerve Growth Factor Receptor
      • 10.2.4 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 10.2.5 Astellas Pharma Inc Recent Development
    • 10.3 AstraZeneca Plc
      • 10.3.1 AstraZeneca Plc Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of High Affinity Nerve Growth Factor Receptor
      • 10.3.4 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 10.3.5 AstraZeneca Plc Recent Development
    • 10.4 Daiichi Sankyo Co Ltd
      • 10.4.1 Daiichi Sankyo Co Ltd Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of High Affinity Nerve Growth Factor Receptor
      • 10.4.4 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 10.4.5 Daiichi Sankyo Co Ltd Recent Development
    • 10.5 Dompe Farmaceutici SpA
      • 10.5.1 Dompe Farmaceutici SpA Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of High Affinity Nerve Growth Factor Receptor
      • 10.5.4 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 10.5.5 Dompe Farmaceutici SpA Recent Development
    • 10.6 Genzyme Corp
      • 10.6.1 Genzyme Corp Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of High Affinity Nerve Growth Factor Receptor
      • 10.6.4 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 10.6.5 Genzyme Corp Recent Development
    • 10.7 Handok Inc
      • 10.7.1 Handok Inc Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of High Affinity Nerve Growth Factor Receptor
      • 10.7.4 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 10.7.5 Handok Inc Recent Development
    • 10.8 Ignyta Inc
      • 10.8.1 Ignyta Inc Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of High Affinity Nerve Growth Factor Receptor
      • 10.8.4 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 10.8.5 Ignyta Inc Recent Development
    • 10.9 Loxo Oncology Inc
      • 10.9.1 Loxo Oncology Inc Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of High Affinity Nerve Growth Factor Receptor
      • 10.9.4 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 10.9.5 Loxo Oncology Inc Recent Development
    • 10.10 Merck & Co Inc
      • 10.10.1 Merck & Co Inc Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of High Affinity Nerve Growth Factor Receptor
      • 10.10.4 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 10.10.5 Merck & Co Inc Recent Development
    • 10.11 Nerviano Medical Sciences Srl
    • 10.12 Plexxikon Inc
    • 10.13 Proximagen Ltd
    • 10.14 Rottapharm Biotech Srl
    • 10.15 Sienna Biopharmaceuticals Inc
    • 10.16 Tiziana Life Sciences Plc

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 High Affinity Nerve Growth Factor Receptor Sales Channels
      • 11.2.2 High Affinity Nerve Growth Factor Receptor Distributors
    • 11.3 High Affinity Nerve Growth Factor Receptor Customers

    12 Market Forecast

    • 12.1 Global High Affinity Nerve Growth Factor Receptor Sales and Revenue Forecast 2019-2025
    • 12.2 Global High Affinity Nerve Growth Factor Receptor Sales Forecast by Type
    • 12.3 Global High Affinity Nerve Growth Factor Receptor Sales Forecast by Application
    • 12.4 High Affinity Nerve Growth Factor Receptor Forecast by Regions
      • 12.4.1 Global High Affinity Nerve Growth Factor Receptor Sales Forecast by Regions 2019-2025
      • 12.4.2 Global High Affinity Nerve Growth Factor Receptor Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of High Affinity Nerve Growth Factor Receptor is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for High Affinity Nerve Growth Factor Receptor.

      This report studies the global market size of High Affinity Nerve Growth Factor Receptor, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the High Affinity Nerve Growth Factor Receptor sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Array BioPharma Inc
      Astellas Pharma Inc
      AstraZeneca Plc
      Daiichi Sankyo Co Ltd
      Dompe Farmaceutici SpA
      Genzyme Corp
      Handok Inc
      Ignyta Inc
      Loxo Oncology Inc
      Merck & Co Inc
      Nerviano Medical Sciences Srl
      Plexxikon Inc
      Proximagen Ltd
      Rottapharm Biotech Srl
      Sienna Biopharmaceuticals Inc
      Tiziana Life Sciences Plc

      Market Segment by Product Type
      ASP-7962
      AZD-7451
      BNN-27
      Cenegermin
      CRB-0089
      Others

      Market Segment by Application
      Bile Duct Cancer
      Papillary Thyroid Cancer
      Low Back Pain
      Lung Cancer
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the High Affinity Nerve Growth Factor Receptor status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key High Affinity Nerve Growth Factor Receptor manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of High Affinity Nerve Growth Factor Receptor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now